Pär Hallberg
Department of Medical Sciences
Clinical Pharmacology
Uppsala University Hospital
Uppsala University
Sweden
Name/email consistency: high
- Digoxin and mortality in atrial fibrillation: a prospective cohort study. Hallberg, P., Lindbäck, J., Lindahl, B., Stenestrand, U., Melhus, H. Eur. J. Clin. Pharmacol. (2007)
- The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. Hallberg, P., Sjöblom, V. J. Clin. Psychopharmacol (2005)
- Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Hallberg, P., Lind, L., Billberger, K., Michaelsson, K., Karlsson, J., Kurland, L., Kahan, T., Malmqvist, K., Ohman, K.P., Nyström, F., Liljedahl, U., Syvänen, A.C., Melhus, H. Clin. Cardiol (2004)
- Acute pancreatitis following medical abortion: Case report. Hallberg, P., Hallberg, E., Amini, H. BMC. Womens. Health (2004)
- Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Hallberg, P., Karlsson, J., Lind, L., Michaëlsson, K., Kurland, L., Kahan, T., Malmqvist, K., Ohman, K.P., Nyström, F., Liljedahl, U., Syvänen, A.C., Melhus, H. Clin. Cardiol (2004)
- B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Hallberg, P., Lind, L., Michaëlsson, K., Karlsson, J., Kurland, L., Kahan, T., Malmqvist, K., Ohman, K.P., Nyström, F., Melhus, H. J. Hypertens. (2003)
- Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy. Hallberg, P., Lind, L., Michaëlsson, K., Kurland, L., Kahan, T., Malmqvist, K., Ohman, K.P., Nyström, F., Liljedahl, U., Syvänen, A.C., Melhus, H. BMC. Cardiovasc. Disord (2003)
- The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Hallberg, P., Karlsson, J., Kurland, L., Lind, L., Kahan, T., Malmqvist, K., Ohman, K.P., Nyström, F., Melhus, H. J. Hypertens. (2002)